SWOG clinical trial number

SWOG-7611

Cis-Diamminedichloroplatinum (II) for Refractory Sarcomas

Closed

Abbreviated Title

Cis-Diamminedichloroplatinum (II) for Refractory Sarcomas

Activated

03/05/1976

Closed

11/08/1978

Publication Information Expand/Collapse

1979

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in advanced soft tissue and bony sarcomas. A Southwest Oncology Group study.

MK Samson;LH Baker;RS Benjamin;M Lane;C Plager Cancer Treat Rep 63(11-12):2027- 2029